Shanghai Orsin Medical Technology Co., Ltd.
Shanghai Orsin Medical Technology Co., Ltd.
products
Home /

products

Customizable Cell Free DNA Precise Non Invasive Prenatal Testing NIPT Tube

Product Details

Place of Origin: China

Brand Name: Orsin

Payment & Shipping Terms

Minimum Order Quantity: 100

Price: Negotiation

Payment Terms: L/C, D/A, D/P, T/T, Western Union

Get Best Price
Chat Now
Specifications
Highlight:

Non Invasive Prenatal Testing NIPT Tube

,

Precise Prenatal Testing NIPT Tube

Color:
Purple
Feature:
Have Sth. Made To Order
Application:
Non Invasive Prenatal Testing (NIPT)
Material:
Glass And Plastic
Advantage:
Sterile And Safe Compatible With Equipment
Color:
Purple
Feature:
Have Sth. Made To Order
Application:
Non Invasive Prenatal Testing (NIPT)
Material:
Glass And Plastic
Advantage:
Sterile And Safe Compatible With Equipment
Description
Customizable Cell Free DNA Precise Non Invasive Prenatal Testing NIPT Tube
Customizable Cell Free DNA Precise Non Invasive Prenatal Testing NIPT Tube
Product Attributes
Color Purple
Feature Custom manufacturing available
Application Non Invasive Prenatal Testing (NIPT)
Material Glass and plastic
Advantage Sterile and safe, compatible with standard equipment
Product Overview

Orsin Medical Technology's Cell-Free DNA (cfDNA) Detection System revolutionizes disease diagnosis and monitoring through cutting-edge liquid biopsy technology. Our solution delivers highly sensitive, non-invasive, and real-time genomic analysis for early cancer screening, prenatal testing, transplant monitoring, and more.

Key Features & Advantages:
  • Ultra-Sensitive Detection - Powered by NGS and proprietary bioinformatics, our platform detects trace cfDNA mutations with >99% accuracy, enabling early disease identification.
  • Minimally Invasive - A simple blood draw replaces risky tissue biopsies, ensuring patient safety and comfort.
  • Multi-Application Flexibility - Covers oncology (early cancer screening, MRD monitoring), NIPT (fetal aneuploidy detection), and transplant rejection tracking.
  • Rapid & Scalable - High-throughput workflow delivers fast, reliable results, ideal for clinical and research use.
  • AI-Enhanced Analysis - Advanced algorithms improve mutation calling, reducing false positives/negatives.
Technical Specifications
Parameter Specification Significance
Sample Input Volume 0.5-4 mL plasma/serum Optimized for low-abundance cfDNA in clinical samples
Extraction Time ≤60 minutes Rapid workflow for high-throughput labs
DNA Yield 70-90% recovery (spiked-in controls) High efficiency for short fragments (50-300 bp)
Purity (A260/A280) 1.7-2.0 Ideal for downstream NGS/PCR without protein/RNA contamination
Fragment Range 50-300 bp (optimized for ≤166 bp) Captures tumor/placental-derived cfDNA
Inhibitor Removal Effective against heparin, hemoglobin, etc. Ensures PCR/NGS compatibility
Automation Compatibility Compatible with major liquid handlers Scalable for clinical/large-scale research
Storage Conditions 2-8°C (stable for 24 months) Long shelf life with minimal batch variability
Common Parameters by Tube Color
Cap Color Additive Mixing Inversion Count Clinical Applications
Red None/Clot activator 5-6 Serum chemistry, Immunology
Purple K2/K3 EDTA 8-10× 8-10 Hematology (CBC, Blood Smear)
Green Lithium Heparin 8-10× 8-10 Plasma chemistry, STAT tests
Gray NaF/K Oxalate 8-10× 8-10 Glucose tolerance, Alcohol tests
Blue Sodium Citrate 3-4× 3-4 Coagulation tests (PT, APTT)
Applications
Hospital Routine Testing

Blood tests for routine diagnostics (CBC, biochemistry, coagulation) in outpatient/inpatient settings.

  • Accurate Volume Control (±5% tolerance) ensures consistent results and reduces retesting rates
  • Multiple additives (EDTA, heparin, sodium citrate) tailored for diverse testing requirements
  • Compatibility with automated analyzers and seamless integration with hospital LIS/HIS systems
Emergency & Critical Care

Rapid analysis of blood gases, electrolytes, and cardiac markers in urgent care.

  • DHA (Dual Hemostasis Activator) Technology accelerates blood separation, reducing preprocessing time (<15 minutes)
  • Gray-top tubes prevent glucose degradation for accurate emergency glucose testing
Research & Laboratory Studies

Genomics (DNA/RNA extraction), proteomics, and drug metabolism research.

  • Sterile, non-pyrogenic design eliminates exogenous contamination
  • Customization options available for high-sensitivity assays
Why Choose Orsin's cfDNA Solution?
  • Clinically Validated - Trusted by leading hospitals and labs
  • Cost-Effective - Reduces unnecessary invasive procedures and long hospital stays
  • Future-Ready - Continuously optimized for emerging biomarkers

Orsin Medical Technology empowers precision medicine with smarter, safer, and faster cfDNA diagnostics. Early detection. Better outcomes.

Send your inquiry
Please send us your request and we will reply to you as soon as possible.
Send